Benitec Biopharma (BNTC) SEC Filings & 10K Form

$8.87
+0.97 (+12.28%)
(As of 05/2/2024 ET)

Recent Benitec Biopharma SEC Filings

DateFilerForm TypeView
04/29/2024
10:44 AM
Benitec Biopharma (Subject)
Oliveira Steven Michael (Filed by)
Form SC 13G
04/18/2024
8:45 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:53 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
11:10 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Benitec Biopharma (Subject)
Form SC 13G/A
03/08/2024
3:17 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
11:15 PM
Benitec Biopharma (Filer)
Form EFFECT
02/26/2024
8:06 AM
Benitec Biopharma (Filer)
Form DEL AM
02/14/2024
5:18 PM
Benitec Biopharma (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SC 13G/A
02/13/2024
7:01 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/13/2024
7:15 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
7:02 PM
Benitec Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/11/2023
11:41 AM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
12/07/2023
6:55 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
6:56 PM
Benitec Biopharma (Issuer)
Francis Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
6:57 PM
Benitec Biopharma (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
6:31 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:00 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
7:03 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
3:31 PM
Benitec Biopharma (Filer)
Form DEFA14A
10/20/2023
5:04 AM
Benitec Biopharma (Filer)
Form DEF 14A
10/16/2023
4:29 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
4:19 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
7:00 AM
Benitec Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/21/2023
7:05 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
4:26 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
10:27 AM
Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
08/18/2023
2:55 PM
Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
08/18/2023
9:50 AM
Benitec Biopharma (Subject)
Oliveira Steven Michael (Filed by)
Form SC 13G/A
08/14/2023
4:10 PM
Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
4:13 PM
Benitec Biopharma (Issuer)
Boston Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
3:01 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
11:15 PM
Benitec Biopharma (Filer)
Form EFFECT
08/07/2023
7:11 AM
Benitec Biopharma (Filer)
Form S-1/A
08/03/2023
7:27 AM
Benitec Biopharma (Filer)
Form S-1/A
07/31/2023
7:34 AM
Benitec Biopharma (Filer)
Form S-1/A
07/25/2023
1:08 PM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2023
3:52 PM
Benitec Biopharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/26/2023
7:01 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:11 PM
Banks Jerel A. (Reporting)
Benitec Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:13 PM
Benitec Biopharma (Issuer)
Boston Megan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
7:01 AM
Benitec Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here
05/15/2023
7:05 AM
Benitec Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BNTC) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners